Cite

HARVARD Citation

    Wu, Y. et al. (2017). Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis. Hematology. 22 (10), pp. 578-584. [Online]. 
  
Back to record